Immune Response to Meningococcal Serogroup C Conjugate Vaccine in Asplenic Individuals

Infection and Immunity

Volumn 72, Issue 1, 2004, Pages 332-337

  Balmer, Paul ^a,c   Falconer, Michelle ^b   McDonald, Paula ^b   Andrews, Nick ^a   Fuller, Emily ^a   Riley, Christine ^a   Kaczmarski, Edward ^a   Borrow, Raymond ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b Chester Microbiology Laboratory   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; MENINGOCOCCAL SEROGROUP C CONJUGATE VACCINE; MENINGOCOCCUS VACCINE; NEIS VAC C; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ASPLENIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPLENECTOMY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MIDDLE AGED; NEISSERIA MENINGITIDIS; SPLENECTOMY;

EID: 0347511911     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.1.332-337.2004     Document Type: Article

References (32)

1. Andrews, N., R. Borrow, and E. Miller. 2003. Validation of serological correlate of protection for meningococcal C conjugate vaccine using efficacy estimates from post-licensure surveillance in England. Clin. Diagn. Lab. Immunol. 10:780-786.
2. Borrow, R., J. Southern, N. Andrews, N. Peake, R. Rahim, M. Acuna, S. Martin, E. Miller, and E. Kaczmarski. 2001. Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naive controls. Vaccine 19:3043-3050.
3. Borrow, R., N. Andrews, D. Goldblatt, and E. Miller. 2001. Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect. Immun. 69:1568-1573.
4. Breukels, M. A., A. Zandvoort, G. P. J. M. van den Dobblesteen, A. van den Muijsenberg, M. E. Lodewijk, M. Beurret, P. A. Klok, W. Timens, and G. T. Rijkers. 2001. Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides. Infect. Immun. 69:7583-7587.
5. Chan, C. Y., D. C. Molrine, S. George, N. J. Tarbell, P. Mauch, L. Diller, R. C. Shamberger, N. R. Phillips, A. Goorin, and D. M. Ambrosino. 1996. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease. J. Infect. Dis. 173:256-258.
6. Chief Medical Officer, Chief Nursing Officer, and Chief Pharmaceutical Officer. 2001. Current vaccine and immunisation issues. In Chief medical officer letters PL/CMO/2001/1, PL/CNO/2001/1, and PL/CPHO/2001/1. Department of Health, London, United Kingdom.
7. Davidson, R. N., and R. A. Wall. 2001. Prevention and management of infections in patients without a spleen. Clin. Microbiol. Infect. 7:657-660.
8. Davies, J. M., R. Barnes, and D. Milligan. 2002. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin. Med. 2:440-443.
9. Eraklis, A. J., S. V. Kevy, L. K. Diamond, and R. E. Gross. 1967. Hazard of overwhelming infection after splenectomy in childhood. N. Engl. J. Med. 276:1225-1229.
10. Fairley, C. K., N. Begg, R. Borrow, A. J. Fox, D. M. Jones, and K. Cartwright. 1996. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J. Infect. Dis. 174:1360-1363.
11. Gheesling, L. L., G. M. Carlone, L. B. Pais, P. F. Holder, S. E. Maslanka, B. D. Plikaytis, M. Achtman, P. Densen, C. E. Frasch, and H. Kayhty. 1994. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J. Clin. Microbiol. 32:1475-1482.
12. Giebink, G. S., J. E. Foker, Y. Kim, and G. Schiffman. 1980. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J. Infect. Dis. 141:404-412.
13. Gold, R., M. L. Lepow, I. Goldschneider, T. L. Draper, and E. C. Gotschlich. 1975. Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. J. Clin. Investig. 56:1536-1547.
14. Kristensen, K. 1992. Antibody response to a Haemophilus influenzae type b polysaccllaride tetanus toxoid conjugate vaccine in splenectomized children and adolescents. Scand. J. Infect. Dis. 24:629-632.
15. Krivit, W. 1977. Overwhelming postsplenectomy infection. Am. J. Hematol. 2:193-201.
16. Kruetzmann, S., M. M. Rosado, H. Weber, U. Germing, O. Tournilhac, H. H. Peter, R. Berner, A. Peters, T. Boehm, A. Plebani, I. Quinti, and R. Carsetti. 2003. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197:939-945.
17. Leach, A., P. A. Twumasi, S. Kumah, W. S. Banya, S. Jaffar, B. D. Forrest, D. M. Granoff, D. E. Libutti, G. M. Carlone, L. B. Pais, C. V. Broome, and B. M. Greenwood. 1997. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal-protein conjugate vaccine. J. Infect. Dis. 175:200-204.
18. Macdonald, N. E., S. A. Halperin, B. J. Law, B. Forrest, L. E. Danzig, and D. M. Granoff. 1998. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers. JAMA 280:1685-1689.
19. Maslanka, S. E., L. L. Gheesling, D. E. Libutti, K. B. Donaldson, H. S. Harakeh, J. K. Dykes, F. F. Arhin, S. J. Devi, C. E. Frasch, J. C. Huang, P. Kriz-Kuzemenska, R. D. Lemmon, M. Lorange, C. C. Peeters, S. Quataert, J. Y. Tai, and G. M. Carlone. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin. Diagn. Lab. Immunol. 4:156-167.
20. Molrine, D. C., G. R. Siber, Y. Samra, D. S. Shevy, K. MacDonald, R. Cieri, and D. M. Ambrosino. 1999. Normal IgG and impaired IgM response to polysaccharide vaccines in asplenic patients. J. Infect. Dis. 179:513-517.
21. Pedersen, F. K., J. Henrichsen, and G. Schiffman. 1982. Antibody response to vaccination with pneumococcal capsular polysaccharides in spleneetomized children. Acta Paediatr. Scand. 71:451-455.
22. Pickering, J., and H. Camphell. 2000. An audit of the vaccination and antibiotic prophylaxis practices amongst patients splenectomised in Lothian. Health Bull. (Edinburgh) 58:390-395.
23. Ramsay, M. E., N. J. Andrews, C. L. Trotter, E. B. Kaczmarski, and E. Miller. 2003. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. Br. Med. J. 326:365-366.
24. Rennels, M., J. King, R. Ryall, S. Manoff, T. Papa, A. Weddle, and J. Froeschle. 2002. Dose escalation, safety and immunogenicity study of a tetravalent meningococcal polysaccharide diphtheria conjugate vaccine in toddlers. Pediatr. Infect. Dis. J. 21:978-979.
25. Richmond, P., R. Borrow, J. Findlow, S. Martin, C. Thornton, K. Cartwright, and E. Miller. 2001. Evaluation of de-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and de-O-acetylated serogroup C strains. Infect. Immun. 69:2378-2382.
26. Richmond, P., R. Borrow, D. Goldblatt, J. Findlow, S. Martin, R. Morris, K. Cartwright, and E. Miller. 2001. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J. Infect. Dis. 183:160-163.
27. Richmond, P., R. Borrow, E. Miller, S. Clark, F. Sadler, A. Fox, N. Begg, R. Morris, and K. Cartwright. 1999. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J. Infect. Dis. 179:1569-1572.
28. Richmond, P., D. Goldblatt, P. C. Fusco, J. D. S. Fusco, L. Heron, S. Clark, R. Borrow, and F. Michon. 2000. Safety and immunogenicity of a new Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine in healthy adults. Vaccine 18:641-646.
29. Richmond, P., E. Kaczmarski, R. Borrow, J. Findlow, S. Clark, R. McCann, J. Hill, M. Barker, and E. Miller. 2000. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J. Infect. Dis. 181:761-764.
30. Salisbury, D. M., and N. T. Begg (ed.) 1996. Immunisation against infectious diseases. HMSO, London, United Kingdom.
31. Webber, S. A., C. G. Sandor, M. W. Patterson, L. A. Mitchell, D. Scheifele, J. J. Ochnio, and P. H. McVerry. 1993. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital asplenia. J. Infect. Dis. 167:1210-1213.
32. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. 1996. Guidelines for the prevention and treatment of infection ill patients with an absent or dysfunctional spleen. Br. Med. J. 312:430-434.